Moneycontrol
Get App
SENSEX NIFTY
you are here:

Prism Medico and Pharmacy Ltd.

BSE Live

Apr 07, 10:09
13.06 -0.68 (-4.95%)
Volume
AVERAGE VOLUME
5-Day
1,859
10-Day
14,898
30-Day
57,130
60
  • Prev. Close

    13.74

  • Open Price

    14.00

  • Bid Price (Qty.)

    13.06 (126)

  • Offer Price (Qty.)

    14.20 (390)

NSE Live

(%)
Volume
No Data Available
  • Prev. Close

  • Open Price

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

Prism Medico and Pharmacy is not listed on NSE

ANNOUNCEMENTS ON Prism Medico

  • Mar 30, 2020 8:33 Source: BSE

    Prism Medico and Pharmacy - Clarification

    With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Prism Medico and Pharmacy Ltd has submitted to BSE a copy of Clarification is enclosed.

  • Mar 25, 2020 13:28 Source: BSE

    Prism Medico and Pharmacy - Clarification sought from Prism Medico and Pharmacy Ltd

    The Exchange has sought clarification from Prism Medico and Pharmacy Ltd on 25th March, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

  • Feb 22, 2020 11:54 Source: BSE

    Prism Medico and Pharmacy - Revised/Resubmission Of Un-Audited Financial Results Quarter Ended 31-12-2019

    Dear Sir/Madam, In reference to your mail dated 11.02.2020, enclosing herewith the revised Standalone and Consolidated Financial Results for the Quarter Ended 31st December, 2019 in accordance with Schedule III format of Companies Act, 2013. We apologise for any inconvenience caused and request you to take the same on records and acknowledge receipt. Thanking You, For PRISM MEDICO & PHARMACY LIMITED Sudhanshu Srivastav Director DIN: 08242441

  • Feb 20, 2020 12:44 Source: BSE

    Prism Medico and Pharmacy - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Paramjeet Kaur

  • Jan 30, 2020 17:35 Source: BSE

    Prism Medico and Pharmacy - Clarification

    With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Prism Medico and Pharmacy Ltd has submitted to BSE a copy of Clarification is enclosed.

  • Jan 30, 2020 14:24 Source: BSE

    Prism Medico and Pharmacy - FINANCIAL RESULTS FOR THE QUARTER ENDED 31.12.2019

    1.Considered and approved the unaudited Standalone and Consolidated Financial Results for the quarter ended 31st December, 2019

  • Jan 30, 2020 14:19 Source: BSE

    Prism Medico and Pharmacy - Outcome Of Board Meeting Held On Thursday, 30Th January, 2020.

    Considered and approved the unaudited Standalone and Consolidated Financial Results for the quarter ended 31st December, 2019

  • Jan 27, 2020 14:10 Source: BSE

    Prism Medico and Pharmacy - Outcome Of Board Meeting Held On Monday, 27Th January, 2020

    1. Pursuant to the resolutions passed at the AGM of the Company. The Board disinvest in the shares of Healthy Biosciences Private Limited. Now, the Company is holding 19.38 % of shares in Healthy Biosciences Private Limited and thus, the Company ceased to be its subsidiary. The 80.62% of holding in the Company were transferred. The SH-4 (Share Transfer Form) was placed before the Board.

  • Jan 22, 2020 10:39 Source: BSE

    Prism Medico and Pharmacy - Board Meeting Intimation for Meeting To Be Held On Thursday, 30Th January, 2020.

    PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2020 ,inter alia, to consider and approve 1.To consider, approve and take on record the unaudited Standalone and Consolidated Financial Results for the quarter ended 31st December, 2019 2.Any other matter with the permission of Chair. Kindly take same on your records. Thanking You,

  • Jan 18, 2020 12:46 Source: BSE

    Prism Medico and Pharmacy - Board Meeting Intimation for Board Meeting To Be Held On Monday, 27Th January, 2020.

    PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2020 ,inter alia, to consider and approve We wish to inform your good self that the meeting of the Board of Directors of our Company will be held on Monday, 27th January, 2020 at the Registered Office of the Company situated at D-118, Industrial Area, Phase VII, Mohali, Punjab-160055, to consider and discuss the following items: 1.To disinvest and transfer the shares of Healthy Biosciences Pvt Limited, pursuant to the resolution passed at the Annual General Meeting of the Company held on 30th September, 2019 2. To authorise the Director to execute and sign the Share Transfer Deed. 3. Any other matter with the permission of Chair. Kindly take same on your records. Thanking You, Yours Truly,

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jan 30, 2020
Remark : Quarterly Results